Fisher & Paykel Healthcare v Flexicare (Group) (CFI, UPC_CFI_480/2025, 15 January 2026)
| Date | 15 January 2026 |
|---|---|
| Court | CFI |
| Division | Milan (IT) Central Division- Section |
| Type of action | Revocation Action |
| Case number(s) | UPC_CFI_480/2025 |
| Registry reference | UPC_CFI_480/2025 |
| Parties | Fisher & Paykel Healthcare Limited v. Flexicare (Group) Limited |
Official decision (PDF) · UPC registry entry
Case timeline
- 15 January 2026 : Fisher & Paykel Healthcare v Flexicare (Group) (CFI, UPC_CFI_480/2025, 15 January 2026, doc. 2) UPC_CFI_480/2025
Dhenne Avocats represents claimants and defendants in European patent disputes before the Unified Patent Court, including the Paris divisions.
Dhenne Avocats · 10 October 2026
Our analysis
Summary
By an order of 15 January 2026 (UPC_CFI_480/2025), the Milan Central Division refused to admit auxiliary requests 2A to 13A, filed « as a mere precaution » by Flexicare, proprietor of EP 4 185 356, in its rejoinder in Fisher & Paykel Healthcare’s revocation action. The order, also published under a second entry in the same file, applies Rule 30.2 strictly: the clarity objection was foreseeable and should have been addressed in the application to amend itself.
Question
May the proprietor introduce new auxiliary requests at the rejoinder stage in response to a clarity objection (Art. 84 EPC) raised in the reply?
Decision
The implicit request for admission was admissible (paragraphs 10 and 11) but refused. Rule 30.2, applicable to revocation actions through Rule 50.2, is a strict preclusion rule allowing subsequent amendments only in exceptional circumstances (paragraph 7). Filing as a precaution is no basis for admission (paragraph 13). The proprietor should and could have foreseen the clarity objection, which had to be dealt with in the application to amend (paragraph 14). The new requests further limit the claim, whereas the Rules aim to prevent amendments being introduced in little steps (paragraph 15). The time left before the oral hearing is not a sufficient reason for admission (paragraph 16).
Key points for practice
- Auxiliary requests should anticipate, from the defence to revocation onwards, the clarity objections that the proposed amendments may attract.
- Filing as a precaution and the time remaining before the hearing are not exceptional circumstances under Rule 30.2.
Provisions applied
- Agreement on a Unified Patent Court
- Preamble
- Rules of Procedure
- Preamble and Rules 30.1(b), 30.2, 49.2(a) and 50.2
- European Patent Convention
- Art. 84 and 123(2) and (3)
- Case law cited
- Meril v Edwards, Paris Central Division, 27 February 2024 (UPC_CFI_255/2023), TRUMPF v IPG, Düsseldorf Local Division, 12 September 2025, Panasonic v OPPO, Mannheim Local Division, 27 June 2024, 10x Genomics v Vizgen, Hamburg Local Division, 20 December 2024
Prepared by Dhenne Avocats from the official decision, consulted on 10 October 2026. The database is updated every week, on Friday. Only the official text is authoritative.
Decisions in the same proceedings
Going further
Lexicon: Revocation action.
Publications by Matthieu Dhenne: G 1/25, Take Three: Anything You Leave in the Description May Be Used Against You (Kluwer Patent Blog).
Source and translations
- Official source
- Unified Patent Court registry link recorded in the record
- Original language
- not recorded
- Translation available
- no translation recorded the firm’s French record is a summary, not a translation
- Date checked
- not recorded
Follow this case
Proceedings, related decisions, appeals, parties and patents as recorded in the registry and in the Dhenne Avocats corpus. Each link states its source.
Parties
- claimantFisher & Paykel Healthcare Limited3 decisions in the corpusFollow this party
- defendantFlexicare (Group) Limited3 decisions in the corpusFollow this party
Decisions in the same proceedings and documented appeals
- 15 January 2026 Fisher & Paykel Healthcare v Flexicare (Group) (CFI, UPC_CFI_480/2025, 15 January 2026) Revocation Action · UPC_CFI_480/2025
- 15 January 2026 Fisher & Paykel Healthcare v Flexicare (Group) (CFI, UPC_CFI_480/2025, 15 January 2026, doc. 2) Revocation Action · UPC_CFI_480/2025
What the record states
- Nature of the act
- Revocation Action
- Outcome (Dhenne Avocats summary)
- Les requêtes subsidiaires 2A à 13A déposées en duplique sont écartées : l'objection de clarté était prévisible et aucune circonstance exceptionnelle n'est établie au sens de la règle 30.2.
- Appeal
- No appeal documented in the corpus, this does not mean that no appeal was lodged.
- Instance
- First-instance decision, whether it has become final is not recorded.
Patents mentioned
EP 4 185 356mentioned in: Dhenne Avocats analysis Follow this patent
Related decisions cited in the analyses
- Fisher & Paykel Healthcare v Flexicare (Group) (CFI, 10 April 2026) cited in this record
- Fisher & Paykel Healthcare v Flexicare (Group) (CFI, UPC_CFI_480/2025, 15 January 2026, doc. 2) cited in this record
- TRUMPF Laser- und Systemtechnik v IPG Laser (CFI, ORD_35954/2025, 12 September 2025) cited in this record
- Panasonic v Guangdong OPPO Mobile Telecomm (CFI, 27 June 2024) cited in this record
- Boa v FLA Europe (CFI, 17 August 2026) cites this decision
Patents and standards
| Publication | Role in the dispute | Family | Standard and declaration | Pool | Sources |
|---|---|---|---|---|---|
EP 4 185 356 | Mentioned in the analysis (role not qualified) Also mentioned in 1 other decision(s): Fisher & Paykel Healthcare v Flexicare (Group) (CFI, 10 April 2026) | not recorded | not recorded | not recorded | Espacenet links not checked mentioned in: Dhenne Avocats analysis |
Receive an alert
Weekly summary of new records and substantive updates matching what you follow. Address confirmed by email, unsubscribe at any time, one email per week even where several of your follows match.